CMS has announced that the Medicare Evidence Development & Coverage Advisory Committee (MedCAC) will meet February 25, 2009 to focus on the requirements for evidence to determine if diagnostic use of genomic testing in beneficiaries with signs or symptoms of disease improves health outcomes in Medicare beneficiaries. The meeting will also discuss the various kinds of evidence that are useful to support requests for Medicare coverage in this field.